Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Impairment in Women With Early Stage Breast Cancer

NCT01553097 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01553097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01553097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Impairment in Women With Early Stage Breast Cancer
Lead sponsor
Virginia Commonwealth University
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2014
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neurocognitive impairment, quality of life